Pre Seed · Healthtech · London, United Kingdom · Founded 2024 · 11–50 employees
ReactWise offers an AI-powered no‑code platform to optimize chemical reaction conditions for pharma development, significantly accelerating process design. It reports industrial case studies including a Pfizer collaboration and claims acceleration of process development by over 50% and achievement of 97.5% yield with 1% impurity in complex reactions. The firm raised substantial pre‑seed funding, including $3.4m from Y Combinator, Innovate UK and others in early 2025, signaling confidence from key innovation investors.